chrisvoncsefalvay/vaers-outcomes huggingface dataset:
At 3:15 PM, itching and redness of the right arm (back of arm). At 3:25 PM, "bubbles" and blotches on the right arm. At 3:45 PM, "bubbles" and blotches covered the entire right arm and the left arm started went to the knees and legs then covered the whole body. At 4:45 PM, at the doctors, trouble with vision, passed out, O2 at 87 %. Treatment O2, Nebulizer, Benadryl IM, Prednisone PO, Allegra, and Zantac.
Headache, Fever, Metallic taste, fatigue, chills, stomach pains. Narrative: Fever mild x24 hours, fatigue moderate, headache mild, chills, metallic taste on the day of injection, stomach pains x10 days. All following second in series vaccination. Resulted in unable to work 1/12/2021.
Information has been received from a physician concerning a 19 year old female, who on an unspecified date, was vaccinated with a first dose of Gardasil vaccine. No adverse symptoms were noted. On 26-OCT-2007, the patient was vaccinated intramuscularly with a 0.5mL second dose of Gardasil vaccine (Lot# "07420"). Subsequently, sometime after 26-OCT-2007 the patient developed a painful rash. The patient called the office. The patient was going to see a dermatologist. At the time of the report, the patient's outcome was unknown. No product quality complaint was involved. Additional information has been requested.
Nearly immediate cold symptoms - congestion which has continued for 5 days now. Chills. Severe redness around injection site which persists after 5 days.
Received vaccines 10/1/18. Patient developed fever on of 10/3/18. Tmax 101. Mom gave Motrin before bed that night. Checked on him before she went to bed and his temp was 99. Next morning he was found dead in crib. No blankets, stuffed animals in crib. Autopsy found no signs of trauma. Tox screen, tissue samples still pending.
About 3-4 days after vaccine noted sores in mouth progressing to herpetic outbreak-inside mouth , on lips and abdomen, Also maybe 5-6 days  I noted bruising on inside thighs, legs, and back of arm. I have antiphospholipid syndrome, autoimmune disorder . I experienced tired ness and weakness. I  reported to nurse by phone and no response. I had asked MD to call back for recommendation -no response
Pfizer-BioNTech COVID-19 Vaccine EUA administration error - vaccine dose given 26 hours after puncture of the vial.  Pfizer offers excursion data for up 24 hours post-puncture.  No symptoms as a result of the administration error.
The patient stated she has a site reaction at the site of the injections. She has a wound that has not healed as of 10/28/19 and is painful and bleeds when irritated by clothing or other things. The patient also stated that she feels weakness and pain in the arm.
Pt with arm swelling seen at Urgent Care and ER and given IV dose antibiotics x 1 and then PO antibiotics, completely resolved.
Localized swelling at site of injection. Given Dytan for swelling 9/22/06. 9/30/06 lesion on trunk swell an red. Given cortisone injection, 10/03/06 lesion also on arms and legs.
Pt vaccinated w/DTP developed erythema multiforme onset 20DEC90.
Same day post vax, pt developed rash all over and was taken by ambulance to the ER with anaphylactic shock (considered an other medical event). At the time of this report, the pt had not yet been  discharged from the ER. Additional information has been requested. Follow up received indicated the pt has recovered. No further information is expected.
Whole body was in severe pain including her teeth; Not able to get up or sit down; she was shivering so bad; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN (Whole body was in severe pain including her teeth), ASTHENIA (Not able to get up or sit down) and CHILLS (she was shivering so bad) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No medical history was reported by the reporter.  Concomitant products included MONTELUKAST SODIUM (SINGULAIR) for Asthma.    On 24-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) 1 dosage form. On 03-Feb-2021, the patient experienced PAIN (Whole body was in severe pain including her teeth), ASTHENIA (Not able to get up or sit down) and CHILLS (she was shivering so bad). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of Advil every 6 hours. At the time of the report, PAIN (Whole body was in severe pain including her teeth), ASTHENIA (Not able to get up or sit down) and CHILLS (she was shivering so bad) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Subcutaneous), the reporter did not provide any causality assessments.   Suspect product Dose 1 body site was updated as upper arm. Patient was taken steroids to relieve the symptoms. After appointments with general practioner for infectious disease, neurology, allergy and immunology along with a  lot of lab/bloodwork, Patient made the decision to go ahead with the second vaccine.   This case was linked.   Most recent FOLLOW-UP information incorporated above includes: On 13-Jul-2021: Follow-up received on 13-JUL-2021: Reporter contact details updated. Secondary reporter details added. Patient demographic details updated. Suspect product body site was updated and route of administration was updated from Intramuscular to Sub cutaneous. Concomitant medication Singulair was updated.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Narrative: COVID infection following COVID vaccine series 03/25, Pfizer dose #1 04/15, Pfizer, dose #2 12/23, Pfizer, dose #3 1/1 COVID swab, result: detected 12/22 pt cc: exposure: unknown 1/1 pt admit Medicine cc: chest/neck/shoulder pain dx: chest pain, covid LOS: 3 days 1/1 TROPONIN I: 0.047 1/1 CRP: 1.621 1/1 CXR IMPRESSION: No pleural effusion or pneumothorax is identified. There is a 1.0 cm nodular density in the left lower lung which could reflect the patient's left nipple. Repeat study with nipple markers is recommended for confirmation to exclude a pulmonary lesion. Cardiomediastinal contours appear within normal limits. 1/2 CTA PE IMPRESSION: 1. No evidence of pulmonary embolism or other acute abnormality in the chest. 2. Mild thyromegaly. Correlate with thyroid function tests. 3. Incidental tiny left pulmonary nodule. If the patient has a history of smoking or other risk factors for lung cancer, a follow-uo chest CT may be obtained in 12 months. Otherwise, no further workup or surveillance is needed per guidelines. 1/2 FIBRINOGEN: 447 1/2 DDIMER: 0.31 1/2 FERRITIN: 250.1 1/2 LACTIC ACID: 0.87 1/2 TROPONIN I: 0.051 1/2 PROCALCITONIN: <0.05 1/2 SARS-COV-2 IGG Eval: 0.01 1/2 BNP: 23.8 1/2 SARS-CoV-2 (COVID-19): >2500.0 1/2 TROPONIN I: 0.047 1/3 FIBRINOGEN: 493 1/3 DDIMER: 0.34 ESR: 36 1/4 FIBRINOGEN: 463 1/4 DDIMER: 0.30 1/4 ESR: 30
After the vaccines he fainted and his father caught him preventing him from hitting his head. He regained consciousness in less than a minute and described feeling dizzy before fainting then tingling in his hands.  We had called 911 and upon examination determined all vitals were normal and the patient and his father left.
About 2-5 minutes after shot, I couldn?t swallow. My throat  muscles just wouldn?t work, but it was really sporadic like  once or twice every 30 seconds-2 minutes I was not able to swallow. After 30 minutes of no worsening and waiting at vaccine site, my throat became itchy on my drive home and i had to clear it often. Rarely this happens to me if I eat honeydew melon or drink soymilk. I went to Urgent Care, throat looked open and they told me to take Benadryl.  I?m curious if you?ve had reports like this of sporadic throat inoperation and if it will happen worse with the second dose.
Pfizer-BioNTech COVID-19 Vaccine EUA Injection site pain and swelling  fever headache joint pain specifically in hands wrists and neck  chills  muscle pain  nausea feeling unwell
This spontaneous report was received from a certified medical assistant and refers to a patient of unknown age and gender. There was no information about patient's pertinent medical history, concomitant medications and drug reactions or allergies reported. On 07-OCT-2015, the patient was vaccinated with an improperly stored dose of MMRII recombinant human albumin (rHA) status (lot# L003859, expiration date, dose, anatomical location and route of administration were not reported). The reason for the temperature excursion was, because the daily vaccine counts caused the storage unit to have temperature fluctuations because of door opening. No adverse events were reported. This is one of the several reports received from the same reporter. Additional information is not expected, as no further information is available.
Reappearance of injection site erythema with induration  and mild pruritus 9 days post vaccination. Localized injection site erythema was present almost immediately after injection lasting 72 hrs, associated with pain and increased warmth, self resolved only to reappear 6 days later without any apparent trigger, not associated with pain.
Within seconds of receiving the vaccine, patient said he felt woozy, slumped forward, Skin cool and clammy. Episode lasted approximately 15 seconds, then patient opened his eyes, asked if he rec'd the shot. Pulse was 60 and faint, kept supine for 15 mins, alert and oriented. Sat on side of exam table, drank 2 small glasses of water, skin warm and dry. Patient did state that he had only a protein bar all morning, and was not drinking much today.
On day 27 after 1st moderna dose, patient's entire body was inflamed.  He was hospitalized at UAB and was given high dose steroids and released after 6 days.  Doctor said they could find nothing to cause the inflammation and his only conclusion was the vaccine.
pt inadvertently recv MR vax instead of Measles vax & devel sleep disturbances; pt recovered by the time of the report; No further details were provided;
This case was reported by a consumer via interactive digital media and described the occurrence of expired vaccine used in a patient who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. Additional details were provided as follows: The patient self-reported the case. The age at vaccination was not reported. The patient received an expired dose of Shingrix. The follow-up could not be possible as no contact details were available.
c/o tingling in tongue, zyrtec 10mg po.  Tingling subsided after 20 minutes
administrated powder with Non-GSK supplied diluent; administrated powder with Non-GSK supplied diluent; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate preparation of medication in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number amca725c, expiry date 30th September 2022) for prophylaxis.   On 7th September 2022, the patient received Menveo. On 7th September 2022, unknown after receiving Menveo, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   Additional Information: GSK Receipt Date: 09-SEP-2022 Reporter's Comment: The reporter reported that, a patient was administrated with the powder component of Menveo with a Non-GSK supplied diluent. No adverse event was reported. The reporter consented to follow up. Additional Supportive Information: The reporter reported that, a patient was administrated with the powder component of Menveo with a Non-GSK supplied diluent, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered.
Information has been received from a registered nurse concerning a female patient who "3 weeks ago" on approximately 26-MAY-2009, was vaccinated with a dose of GARDASIL. Concomitant therapy included MENACTRA and other unspecified vaccines which were also given. On approximately 26-MAY-2009, after receiving the dose of GARDASIL the patient experienced syncope and turned blue. Oxygen was administered. The patient sought medical attention. The patient recovered within 20 minutes after the dose of GARDASIL was given. Follow-up information was received from a registered nurse concerning a 15 year old female patient. It was reported that on 12-MAY-2009, the patient received the first dose of GARDASIL (LOT # 661703/0651X). On 12-MAY-2009 the patient concomitantly received Tdap (manufacturer unknown) (LOT # C3029AA) and Hep A (manufacturer unknown) (LOT # AHABB319AA). It was reported that the patient did not receive concomitantly MENACTRA. After the patient had received GARDASIL, the patient became pale and light-headed. The patient never completely fainted. The patient's lips turned blue and the patient required oxygen for about 10 minutes. It took the patient "a long time before she felt normal". It was reported that the patient had eaten lunch before going to the physician's office. No further information is available.
Information has been received from an approximately 47 year old male physician with CIPD, which is an autoimmune neuropathy who on approximately 10/07/2004 was vaccinated in the deltoid with a second dose of pneuomococcal 23v polysaccharide vaccine.  He reported that he experienced burning when the vaccine was injected and that post-vaccination his left arm was sore and he could not lift it for 3-4 days.  No medical attention was sought.  The physician noted that he received 2 doses of the vaccine over a period of 1.5 years.  He did not want his physician contacted.  No product quality complaint was involved.  Additional information has been requested.
C/O leg pain, had 3" red area on right thigh, hives on his face. No wheezing or respiratory distress.  Advised to apply cool compress to red area, give Benadryl for itching, Tylenol prn.  (Two year old sib received same vaccine at the same time with no adverse reaction.)
After the nurse injected the needle, she pushed the plunger and most (or almost all) of the vaccine solution sprayed out from the joint of the hub and the syringe and ran down the patients arm.  The nurse and the patient both felt that very little, if any, of the vaccine solution entered the arm.  Notified the doctor on call who advised to give a full dose on the same day.   The second attempt at vaccination with a full dose of Moderna #1 was completed.
administered with vaccine which was stored at room temp more than 24 hours; administered with vaccine which was punctured for more than 12 hours; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered with vaccine which was punctured for more than 12 hours) and PRODUCT STORAGE ERROR (administered with vaccine which was stored at room temp more than 24 hours) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048L21A, 012L20A, 016M20A and 045C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-May-2022 at 9:30 AM, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered with vaccine which was punctured for more than 12 hours). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (administered with vaccine which was stored at room temp more than 24 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered with vaccine which was punctured for more than 12 hours) and PRODUCT STORAGE ERROR (administered with vaccine which was stored at room temp more than 24 hours) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant were reported. The vial was pulled out of the refrigerator at 8:00 am on 12-May-2022, punctured around 8:15 am and left at room temp since then. The vial was initially stored in the refrigerator on 02-May-2022 in the morning. t It was reported that the vial did not undergo any temperature excursions. The patient does not have any side effects at the time of the call. No treatment were reported.
Swelling of left lymph node under left armpit; This is a spontaneous report from a contactable consumer (patient). A 32-year-old female patient received second dose BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration in the left arm on 19Jan2021 12:45 at a single dose for COVID-19 immunization. Medical history was none. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), colecalciferol (VITAMIN D), and ethinylestradiol, norgestimate (SPRINTEC). Historical vaccine included first dose of PFIZER BIONTECH COVID 19 VACCINE on 29Dec2020 12:30 PM in the left arm for COVID-19 immunization when the patient was 32 years old. The patient was not pregnant. The patient had not received any other vaccine prior to covid vaccine. The patient experienced swelling of left lymph node under left armpit on 20Jan2021 22:15 with outcome of not recovered. Therapeutic measure was taken as a result of swelling of left lymph node under left armpit (lymphadenopathy) with OTC ADVIL.The patient had no covid prior vaccination nor was he tested post vaccination.   Information on Lot/Batch number has been requested.
First Vaccine: A little achy; This is a spontaneous report received from contactable reporter(s) (Other HCP) for a Pfizer sponsored program. The reporter is the patient.  A 85 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm, administration date 10Feb2021 (Lot number: EN6203) at the age of 85 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "pacemaker" (ongoing); "Bovine Valve Implant" (unspecified if ongoing); "Abdominal Aneurysm with 2 Stents" (unspecified if ongoing). The patient took concomitant medications. The following information was reported: PAIN (non-serious), outcome "recovered", described as "First Vaccine: A little achy". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of pain. Additional information: The patient stated that he was pleased to tell Pfizer, he was 86 years (at the time of report) old and he had both shots and also had the first booster shot and those 3 shots he had no reaction whatsoever. The patient stated the route of administration was arm intramuscular. The patient stated again, he is 86 years old and has had all 3 shots, with no reaction, whatsoever, except the first time he was a little achy, but he took an aspirin and the achiness went away. The patient stated with the second, he was a little itchy, but he took a Benadryl and it knocked out the itchiness from the second shot and he has been fine ever since. The patient stated the very minor side effects he experienced were transient and they didn't last. The patient was using Heart Medication as concomitant medication. The patient mentioned that he was taking Covid 19 Vaccine to prevent dying.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200341941 same patient, product, different dose
11/08/2009, I got up from laying down to go to bed and experienced a chronic nose bleed out of both nostrils and was coughing up blood (from nose bleed) for 25 minutes. I called 911 and the Paramedics told me to pinch nose and apply ice. After 40 minutes it stopped. Today, 11/11/2009 I have a swollen left eye and soreness all around my left sinus region. I am taking an anti-immflammatory drug for the swelling.
Vaccine adminsted too soon, patient notified, no adverse reaction noted or reported at time patient notified of error via Telephone. pt. was notified of this close not being a valid booster. would need a repeat in 5 months. patient verbalized understanding
other zoster related injuries; shingles; Information has been received from a lawyer and an elderly patient of unknown age and gender regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. In or about 2014 (at approximately 78 years old), the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot#, expiration date and route unknown) for the long-term prevention of shingles and zoster-related conditions. Subsequently, the patient was treated by a physician and other healthcare providers for the following injuries resulting from zoster vaccine live (ZOSTAVAX): shingles and other zoster related injuries. The outcome of these events was unknown.
A report has been received from a Health Professional concerning a 52 year old, female subject, who had been receiving FLUMIST QUADRIVALENT (intranasal). FLUMIST QUADRIVALENT (intranasal) started on 12-Sep-2014. The patient experienced administered FLUMIST QUADRIVALENT to a doctor who is over 49 which started on 12-Sep-2014. The outcome of the event of administered FLUMIST QUADRVIALENT to a doctor who is over 49 is unknown. The report was considered to be non-serious by the reporter.
Immediately after receiving the flu vaccine, became sick with the flu. Serious fatigue, fever, headache, elevated temperature. A follow up report received 10/22/2003 adds: Plus ringing in ears.
I was diagnosed with premature menopause at age 30. Shortly after second dose, I had a heavy menstrual period. I haven't had one in years. Especially while taking hormone replacement regularly.
VERY SORE ARM WITH EXCRUCIATING PAIN FOR ALMOST 4 MONTHS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on 26-MAY-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced very sore arm with excruciating pain for almost 4 months. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from very sore arm with excruciating pain for almost 4 months. This report was non-serious.
Client had smallpox vaccine administered on 3-6-03 at Health Dept. Take response completed 3-13-03. On 3-15-03 client observed reddened area under arm with some mild discomfort in armpit that was gone after several hours.